Time to response to citalopram treatment for agitation in Alzheimer's disease

BACKGROUND: Agitation is a common and significant problem in Alzheimer’s disease (AD). In the recent Citalopram for Agitation in Alzheimer’s Disease (CitAD) study, citalopram was efficacious for the treatment of AD agitation. Here we examined the time course and predictors of response to treatment....

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Am J Geriatr Psychiatry
Hlavní autoři: Weintraub, Daniel, Drye, Lea T., Porsteinsson, Anton P., Rosenberg, Paul B., Pollock, Bruce G., Devanand, D.P., Frangakis, Constantine, Ismail, Zahinoor, Marano, Christopher, Meinert, Curtis L., Mintzer, Jacobo E., Munro, Cynthia A., Pelton, Gregory, Rabins, Peter V., Schneider, Lon S., Shade, David M., Yesavage, Jerome, Lyketsos, Constantine G.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2015
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4653092/
https://ncbi.nlm.nih.gov/pubmed/26238225
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jagp.2015.05.006
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky